Wells Fargo & Company »

Contineum Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-09-30 $40k 2.1k 19.14
2024-06-30 $45k 2.5k 17.61